Alvar Paz

Alvar Paz is an accomplished executive with extensive experience in the pharmaceutical and biotechnology industries, currently serving as SVP General Manager, Head Europe at Novavax Inc. since November 2022, where responsibility includes overseeing the commercialization of a major COVID-19 vaccine and managing a Multi-Million P&L. Prior roles include VP & Managing Director at Corza Medical, where leadership focused on growth markets and alliance management, and Sr. Director International Partnering at Emergent BioSolutions, with key roles in business development and marketing for vaccines. Earlier experience encompasses positions in marketing, business development, and brand management at Novartis, Takeda, and GSK, demonstrating a consistent track record in driving strategic growth and managing complex stakeholders. Alvar Paz holds an Innovation and Strategy Diploma from Stanford University and an MBA from Edinburgh Business School.